18.3.2020
•
News
KSB scores again in the current Chambers Europe Yearbook
The renowned British rating company Chambers and Partners once again recommends Kocián Šolc Balaštík in its current publication “Chambers Europe 2020”.
This time KSB has succeeded in nine categories:
- Banking & Finance
- Capital Markets
- Competiton / Antitrust
- Compliance
- Corporate / M&A
- Dispute Resolution
- Employment
- Projects & Energy
- Tax
We greatly being ranked in all this categories. We are pleased that in all categories we have been repeatedly (often for many years), which demonstrates the continued quality of our legal and tax services. We would like to thank all our clients and business partners for their trust in us, thanks to which we continuously maintain an exceptionally good position among law firms in the Czech Republic.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
